Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Cor
(NQ:
EXAS
)
52.91
-0.16 (-0.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
1 Beaten-Down Cathie Wood Stock to Buy and Hold
April 04, 2024
This company is innovating where it matters most, which could prove highly lucrative down the road.
Via
The Motley Fool
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
April 04, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.
Via
Investor's Business Daily
ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday
April 02, 2024
U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
(EXAS) - Analyzing Exact Sciences's Short Interest
April 01, 2024
Via
Benzinga
2 Beaten-Down Cathie Wood Stocks With Massive Potential
March 11, 2024
They won't lag the market forever.
Via
The Motley Fool
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 29, 2024
Via
Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...
Via
Benzinga
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
March 28, 2024
From
Exact Sciences Corp.
Via
Business Wire
Earnings Preview For Exact Sciences
February 20, 2024
Via
Benzinga
Cathie Wood Is Selling This Stock: Should You?
February 07, 2024
This company hasn't performed well in the past 12 months.
Via
The Motley Fool
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
March 27, 2024
From
Exact Sciences Corp.
Via
Business Wire
3 Growth Stocks to Buy at 52-Week Lows in March
March 26, 2024
Wager on these growth stocks to buy at 52-week lows offering robust investment potential ahead for savvy investors.
Via
InvestorPlace
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
March 13, 2024
From
Exact Sciences Corp.
Via
Business Wire
Cathie Wood Darling Exact Sciences Could Pop After Its Next-Gen Product Outperforms
March 13, 2024
Exact Sciences is hoping to launch an next-generation version of Cologuard in 2025.
Via
Investor's Business Daily
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the...
Via
Talk Markets
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
March 07, 2024
From
Exact Sciences Corp.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
March 04, 2024
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
7 Stable Stocks to Buy for 100% Returns by 2025
March 04, 2024
If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.
Via
InvestorPlace
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
March 03, 2024
While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential.
Via
InvestorPlace
3 Hot Stocks Bought by Members of Congress: Follow the Money
March 01, 2024
Palo Alto Networks, Simon Property Group and JPMorgan Chase are the top three stocks bought by Members of Congress in February;
Via
MarketBeat
Exact Sciences to Participate in March Investor Conference
February 26, 2024
From
Exact Sciences Corp.
Via
Business Wire
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speeches, weekly jobless claims data, and private-sector activity readings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript
February 22, 2024
EXAS earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Exact Sciences Announces Fourth Quarter 2023 Results
February 21, 2024
From
Exact Sciences Corp.
Via
Business Wire
Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
February 21, 2024
The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.